Brainbees Solutions and DF Pharmacy Analyzed
Brainbees Solutions, the company behind brands like Babyhug, has made a significant investment in DF Pharmacy, a company focused on health products. They increased their ownership stake from 60% to 80% through a cash payment of Rs 21.56 crore. This strategic move could impact Brainbees Solutions’ growth and market position.
Key Points
- Brainbees boosted DF Pharmacy stake to 80% via cash payment.
- Investment: Rs 21.56 crore completed on November 21, 2025.
- DF Pharmacy sells health products like Kozicare and Healthvit.
- Revenue increased to Rs 2099.08 crore in Q2 FY25.
- Brainbees reported a net loss of Rs 35.05 crore in Q2.
- Related party transaction, executed at arms-length, no approvals needed.
DF Pharmacy was established in 2008 and specializes in nutraceuticals and pharmaceuticals. They own brands like Kozicare, Glutalight, Cleno and Healthvit. These products are often sold to retailers and directly to consumers.
In the second quarter of fiscal year 2025 (Q2 FY25), Brainbees Solutions reported a net loss of Rs 35.05 crore. However, their net sales rose by 10.19% year-over-year, reaching Rs 2099.08 crore. This increase in sales indicates some market demand.
Brainbees Solutions’ overall business includes wholesale trade and contract manufacturing of baby and kids products, alongside education and training services. They also operate their own retail chain, Babyhug, giving them a wide reach within the mother and child market.
The company’s customer base is diverse, encompassing retailers, new and expectant parents, and educational institutions. The share price of Brainbees Solutions dipped slightly, falling 1.32% to Rs 316.95 on November 21, 2025, reflecting investor reaction to the news.
This investment highlights Brainbees Solutions’ focus on expanding its presence in the rapidly growing health and wellness sector.
